Related Experiment Video
Updated: Aug 24, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review
Eva Negri1, D'Anna Little, Mauro Boiocchi
1Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. evanegri@marionegri.it
Insights
Hepatitis C virus (HCV) infection is linked to B-cell non-Hodgkin's lymphoma (B-NHL) in specific regions, with a weak association. Even in high-prevalence areas, HCV accounts for a small percentage of B-NHL cases.
Area of Science:
- Hepatology
- Oncology
- Epidemiology
Background:
- Hepatitis C virus (HCV) infection prevalence in B-cell non-Hodgkin's lymphoma (B-NHL) patients varies geographically.
- Previous studies show inconsistent associations between HCV and B-NHL.
Purpose of the Study:
- To systematically review HCV prevalence in B-NHL case series.
- To determine the odds ratio of B-NHL associated with HCV infection where control groups were available.
Main Methods:
- Systematic literature review of case series focusing on B-NHL.
- Analysis of HCV infection prevalence and odds ratios for B-NHL in relation to HCV.
Main Results:
- High HCV prevalence in B-NHL observed in Southern/Eastern Europe, Japan, and Southern US, but not in Northern/Central Europe, Canada, Northern US, or some Asian countries.
- The odds ratio for B-NHL associated with HCV infection was generally weak, ranging from 2 to 4.
- HCV accounts for a low percentage (up to 10%) of B-NHL cases, even in high-prevalence regions, explaining study inconsistencies.
Conclusions:
- Geographic variations in HCV prevalence influence the observed association with B-NHL.
- The causal link between HCV and B-NHL, if present, contributes minimally to the overall burden of B-NHL.
- Further research into potential mechanisms of action is warranted.
Abstract:
A high prevalence of hepatitis C virus (HCV) infection in patients with B-cell non-Hodgkin's lymphoma (B-NHL) has been reported in some, but not all, studies, and the association showed a strong regional variation. We conducted a systematic review of the prevalence of HCV infection in case series of B-NHL and, when an appropriate control group was available, of the odds ratio of B-NHL associated with HCV infection. A high HCV prevalence in B-NHL was found in southern and eastern Europe, Japan and the southern United States, but not in central and northern Europe, Canada, northern United States, or a few Asian countries. Possible sources of heterogeneity and bias are discussed. The odds ratio of B-NHL for HCV infection was relatively weak, ranging from 2 to 4 in most studies. Thus, even if the observed association were causal, the percentage of cases of B-NHL attributable to HCV infection would be relatively low (10%) also in countries with a high prevalence of HCV infection in the general population, and extremely low in other countries. This may explain apparent inconsistencies between studies. Potential mechanisms of action are also discussed.
More Related Videos
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cytomegalovirus Disease

